Study Title: Phase Ib study of the safety and efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in patients with relapsed or refractory CD33+ acute myeloid leukemia: Big Ten Cancer Research Consortium BTCRC-AML17-113
 

• Closed to Accrual at:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Fred & Pamela Buffett Cancer Center (University of Nebraska)
• Learn more:
  • clinicaltrials.gov: NCT04070768
  • Big Ten CRC News Release
• Publications and Presentations:
  • Poster: 2021 AACR Annual Meeting
  • Poster: 2020 ASCO Annual Meeting

Study Contact: studies@hoosiercancer.org; (317) 921-2050.